According to Vision Research Reports, the global orthopedic biomaterials market size surpassed at US$ 11.7 Bn in 2020 and is expected to grow at a CAGR of 7.3% from 2021 to 2028.
Global orthopedic biomaterials market size is projected to surpass US$ 21.5 billion by 2028.
Rise in percentage of population requiring orthopedic implants, and increase in incidence rate of injuries related to accidents, sports, and adventure are anticipated to augment the global orthopedic biomaterials market from 2021 to 2028. North America and Western Europe are expected to account for significant shares of the global orthopedic biomaterials market. The U.S. is likely to continue its dominance in the orthopedic biomaterials market during the forecast period. The country is likely to witness changes in reimbursement policies in the near future, aimed at increasing the quality of patient care.
According to the Centers for Disease Control and Prevention, in the U.S., annually 54.4 million adults are diagnosed with arthritis. Asia Pacific is projected to be a highly lucrative market for orthopedic biomaterials in the next few years. However, high competition is anticipated to restrain the global orthopedic biomaterials market.
Overview
Drivers
Rise in Percentage of Population Requiring Orthopedic Devices
The population more prone to orthopedic diseases primarily includes obese and geriatric populations. Cartilages become prone to strain and fatigue due to less water content as age progresses. This leads to arthritis and other complications, which require knee replacement procedures. Furthermore, other connective tissues such as ligaments attached to the bones become less flexible and more constrained. These factors are expected to drive the demand for orthopedic devices among the geriatric population. Prevalence of osteoarthritis, rheumatoid arthritis, fibromyalgia, juvenile arthritis, and other forms of orthopedic disorders is increasing primarily due to aging population, obesity, and changes in lifestyle.
Increase in Incidence Rate of Injuries Related to Accidents, Sports, and Adventure
Incidence of accidental injuries during sports, driving, and adventure has increased drastically in the last decade. A study carried out by the American Academy of Orthopedic Surgeons (AAOS) revealed that around 25% of sports injuries were related to lower extremities such as ankle and foot. Serious bone injuries have been reported recently among professionals as well as amateur sportspersons. Over 340,000 hip implant procedures are performed in the U.S. each year, which includes a number of patients aged between 40 and 50 who are focused toward maintaining a healthy lifestyle.
Product Recalls Affecting Adoption Rates to Restrain Market
Incidences of product recalls due to device inefficiency or manufacturing errors affect the adoption rate of these devices among surgeons and patients, thereby affecting revenue of the manufacturers. The global orthopedic biomaterials market has seen various product recalls in the past few years. In April 2017, Zimmer Biomet Holdings, Inc. recalled its class I devices SpF PLUS-Mini and SpF XL IIb implantable spinal fusion stimulators due to potential release of cytotoxic chemical higher than allowed levels. The company also recalled its Comprehensive Reverse Shoulder in June 2016, owing to high fracture rate.
Market Segmentation
Stakeholder Likely to Explore Benefits of 3D Printing for Tissue Engineering
Advancement in the 3D printing technology is expected to create a strong impact on the orthopedic biomaterials market during the forecast period, as stakeholders continue to explore its potential for tissue engineering. 3D printed implants, smart biomaterials, and porous structures are some of the trends one can expect within the orthopedic biomaterials market during the forecast period. These advancements in the orthopedic biomaterial market are anticipated to play a key role in the development of implants with improved functionalities. Although the commercialization of these orthopedic biomaterials was a major challenge for a considerable time period, at present, the adoption of orthopedic biomaterials is on the rise. Furthermore, due to drawbacks of conventional orthopedic biomaterials, including quality, implant life, and cost of the treatment, demand for advanced orthopedic biomaterials is projected to grow at a healthy pace during the assessment period, thus driving the orthopedic biomaterials market.
Innovations to Fuel Adoption of Smart Biomaterials
In the past few years, there have been significant innovations in the regenerative medicines space due to the benefits of biomaterials. At present, biomaterial-based tissue engineering strategies are offering promising results due to which the demand for such ‘smart’ biomaterials is expected to witness substantial growth. Staggering developments as far as stem-cell-based techniques are concerned to have gradually opened the door for new and effective solutions to treat a range of diseases. In the current scenario, owing to the progress in nanotechnology, both natural as well as artificial biomaterials can be deployed to produce 3D scaffolds. Stakeholders in the current orthopedic biomaterials market are seeking solutions to improve the integration of implants made from orthopedic biomaterials. Research and development activities are focusing on finding new techniques wherein orthopedic biomaterials can be used to enhance healing and restoring different physiological functions of the bone. Modern-day bone tissue engineering techniques have largely benefitted from the use of biomaterials to create 3D biodegradable and porous bioactive scaffolds.
Asia Pacific Orthopedic Biomaterials Market to Expand Significantly
Large population base, rise in incidence of orthopedic diseases, and improving economy in China, India, and others countries in Southeast Asia resulting in high per capita health care expenditure, are anticipated to drive the orthopedic biomaterials market in the region. The market is this region is highly price sensitive and Government cap, such as in India, controls most of the prices for orthopedic implants and other devices. The orthopedic biomaterials market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2028.
Key players operating in the global orthopedic biomaterials market include
Market Segmentation
By Material
By Application
By End User
By Region
Report Scope
The Orthopedic biomaterials market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Orthopedic biomaterials market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Orthopedic biomaterials market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthopedic biomaterials market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Orthopedic biomaterials market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Orthopedic biomaterials capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Orthopedic biomaterials by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Orthopedic biomaterials market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Orthopedic biomaterials market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Orthopedic biomaterials market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Orthopedic biomaterials industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Orthopedic biomaterials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Orthopedic biomaterials market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Orthopedic biomaterials market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Orthopedic biomaterials market. These factors have benefited the growth of the global market for Orthopedic biomaterials. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Orthopedic biomaterials. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Orthopedic biomaterials are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Orthopedic Biomaterials Market, By Application
7.1. Orthopedic Biomaterials Market, by Application, 2021-2028
7.1.1. Orthopedic Implants
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Joint Replacement/Reconstruction
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Orthobiologics
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Viscosupplementation
7.1.4.1. Market Revenue and Forecast (2016-2028)
7.1.5. Bio-resorbable Tissue Fixation
7.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Orthopedic Biomaterials Market, Material Type
8.1. Orthopedic Biomaterials Market, Material Type, 2021-2028
8.1.1. Ceramics & Bioactive Glasses
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Polymers
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Calcium Phosphate Cement
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Metal
8.1.4.1. Market Revenue and Forecast (2016-2028)
8.1.5. Composites
8.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Orthopedic Biomaterials Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2016-2028)
9.1.2. Market Revenue and Forecast, Material Type (2016-2028)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.1.3.2. Market Revenue and Forecast, Material Type (2016-2028)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.1.4.2. Market Revenue and Forecast, Material Type (2016-2028)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.2. Market Revenue and Forecast, Material Type (2016-2028)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.3.2. Market Revenue and Forecast, Material Type (2016-2028)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.4.2. Market Revenue and Forecast, Material Type (2016-2028)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.5.2. Market Revenue and Forecast, Material Type (2016-2028)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.6.2. Market Revenue and Forecast, Material Type (2016-2028)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.2. Market Revenue and Forecast, Material Type (2016-2028)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.3.2. Market Revenue and Forecast, Material Type (2016-2028)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.4.2. Market Revenue and Forecast, Material Type (2016-2028)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.5.2. Market Revenue and Forecast, Material Type (2016-2028)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.6.2. Market Revenue and Forecast, Material Type (2016-2028)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.2. Market Revenue and Forecast, Material Type (2016-2028)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.3.2. Market Revenue and Forecast, Material Type (2016-2028)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.4.2. Market Revenue and Forecast, Material Type (2016-2028)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.5.2. Market Revenue and Forecast, Material Type (2016-2028)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.6.2. Market Revenue and Forecast, Material Type (2016-2028)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.5.2. Market Revenue and Forecast, Material Type (2016-2028)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.5.3.2. Market Revenue and Forecast, Material Type (2016-2028)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.5.4.2. Market Revenue and Forecast, Material Type (2016-2028)
Chapter 10. Company Profiles
10.1. DSM Biomedical
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Evonik Industries AG
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Stryker Corp.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. DePuy Synthes Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Zimmer Biomet
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Invibio Ltd.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Globus Medical
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Exactech, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Matexcel
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. AdvanSource Biomaterials Corp.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. CAM Bioceramics B.V.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Heraeus Holding
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms